APA (7th ed.) Citation

Lodde, M., Mian, C., Mayr, R., Comploj, E., Trenti, E., Melotti, R., . . . Pycha, A. (2014). Response to Editorial Comment from Dr Todenhöfer and Dr Schwentner to Recurrence and progression in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading. International Journal of Urology, 21(10), 974. https://doi.org/10.1111/iju.12531

Chicago Style (17th ed.) Citation

Lodde, Michele, et al. "Response to Editorial Comment from Dr Todenhöfer and Dr Schwentner to Recurrence and Progression in Patients with Non-muscle Invasive Bladder Cancer: Prognostic Models Including Multicolor Fluorescence in Situ Hybridization Molecular Grading." International Journal of Urology 21, no. 10 (2014): 974. https://doi.org/10.1111/iju.12531.

MLA (9th ed.) Citation

Lodde, Michele, et al. "Response to Editorial Comment from Dr Todenhöfer and Dr Schwentner to Recurrence and Progression in Patients with Non-muscle Invasive Bladder Cancer: Prognostic Models Including Multicolor Fluorescence in Situ Hybridization Molecular Grading." International Journal of Urology, vol. 21, no. 10, 2014, p. 974, https://doi.org/10.1111/iju.12531.